Back to search
FDAFDA · Food and drugs·Recall number Z-1757-2013

AlboGraft Knitted with Collagen, Bifurcate 18x09 Catalog Number: AMC1809 AlboGraft Vascular Grafts are made of synthetic material and designed to replace sections of damaged or malfunctioning arteries.

Published July 31, 2013 · Recall initiated: June 17, 2013

Summary

FDA records medical device Class I recall Z-1757-2013, published July 31, 2013 and initiated June 17, 2013. Recalling firm: LeMaitre Vascular, Inc.; Status: Terminated; Reported quantity: 3 units; Lot: Lot number/Expiration Date 56890A 2015-04. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Blood blushing/leaking from the surface of the graft after implantation

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
LeMaitre Vascular, Inc.
Distributor
Worldwide distribution: USA including PA and countries of: BRAZIL, BULGARIA, FRANCE, GEORGIA, GERMANY, GREECE, ITALY, LEBANON, NETHERLAND, POLAND, SPAIN, and TURKEY.
Lot
Lot number/Expiration Date 56890A 2015-04
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was AlboGraft Knitted with Collagen, Bifurcate 18x09 Catalog Number: AMC1809 AlboGraft Vascular Grafts are made of synthetic material and designed to replace sections of damaged or malfunctioning arteries. recalled?

Yes. FDA published recall Z-1757-2013 on July 31, 2013. Reported hazard: Blood blushing/leaking from the surface of the graft after implantation

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit